GLGLENVIEW CAPITAL MANAGEMENT, LLC
Institutional investor · Portfolio as of Q1 2019
Top Holdings45 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
DXC TECHNOLOGY CO | 11M | $707M | 6.3% | $52.72 | +17.65% | 2 qtrssince 2018-Q4 | Increased 74 |
FMC CORP | 9.2M | $704.2M | 6.3% | $52.60 | +20.87% | 2 qtrssince 2018-Q4 | Increased 64 |
THE CIGNA GROUP | 4.4M | $703.9M | 6.3% | $164.02 | -10.32% | 2 qtrssince 2018-Q4 | Increased 90 |
MCKESSON CORP | 4.9M | $575.8M | 5.1% | $105.01 | +6.13% | 2 qtrssince 2018-Q4 | Increased 68 |
IQVIA HOLDINGS INC | 3.9M | $562.5M | 5.0% | $113.91 | +26.28% | 2 qtrssince 2018-Q4 | Decreased 0 |
HCA HOLDINGS INC | 4.2M | $553.3M | 4.9% | $115.24 | +6.73% | 2 qtrssince 2018-Q4 | Decreased 0 |
TAKEDA PHARMACEUTIC-SP ADR | 26.1M | $531.9M | 4.7% | $19.07 | 0.00% | 1 qtr | New 88 |
HOLOGIC INC | 10.8M | $520.7M | 4.6% | $41.07 | +17.84% | 2 qtrssince 2018-Q4 | Increased 64 |
TENET HEALTHCARE CORP | 17.9M | $516.3M | 4.6% | $17.30 | +66.67% | 2 qtrssince 2018-Q4 | Increased 58 |
ALPHABET INC-CL A | 405,988 | $477.8M | 4.3% | $51.94 | +12.44% | 2 qtrssince 2018-Q4 | Decreased 0 |
FIRST DATA CORP NEW | 14.6M | $382.3M | 3.4% | — | — | 2 qtrssince 2018-Q4 | Decreased 0 |
LYONDELLBASELL INDU-CL A | 4.3M | $360.8M | 3.2% | $54.01 | +0.73% | 2 qtrssince 2018-Q4 | Increased 93 |
HUMANA INC | 1.3M | $349M | 3.1% | $253.01 | -0.83% | 2 qtrssince 2018-Q4 | Increased 93 |
ANTHEM INC | 1M | $292.2M | 2.6% | $239.87 | +9.33% | 2 qtrssince 2018-Q4 | Increased 62 |
NXP SEMICONDUCTORS NV | 3.2M | $286.3M | 2.6% | $74.22 | +6.73% | 2 qtrssince 2018-Q4 | Increased 86 |
UNIVERSAL HEALTH SERVICES-B | 2.1M | $275.3M | 2.5% | $113.30 | +14.40% | 2 qtrssince 2018-Q4 | Increased 57 |
THERMO FISHER SCIENTIFIC INC | 980,589 | $268.4M | 2.4% | $218.44 | +23.14% | 2 qtrssince 2018-Q4 | Decreased 0 |
BAUSCH HEALTH COS INC | 9.3M | $230.1M | 2.1% | $20.52 | +20.38% | 2 qtrssince 2018-Q4 | Increased 71 |
MICROSOFT CORP | 1.9M | $224.3M | 2.0% | $99.70 | +11.16% | 2 qtrssince 2018-Q4 | Increased 74 |
WILLIAMS COS INC | 7.5M | $215.1M | 1.9% | $14.57 | +35.55% | 2 qtrssince 2018-Q4 | Decreased 0 |
GLENVIEW CAPITAL MANAGEMENT, LLC manages $11.2B across 45 positions as of Q1 2019. Top holdings: DXC (6.3%), FMC (6.3%), CI (6.3%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 4/5.0.
Active quarter - 10 new positions, 13 exits, 20 increased. Top move: LYB (INCREASED, conviction 93). Portfolio: $11.2B across 45 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer